Scholar Rock Holding Corporation
NASDAQ:SRRKBiotechnology
+$0.49 today
- Market cap
- $5.86B
- Beta
- 0.69
- P/E (TTM)
- -14.8
- EPS (TTM)
- -$3.21
Volume 2.77M
Average 1.46M
SRRK Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Scholar Rock Holding CorporationNASDAQ: SRRK
Other Income / Expenses · Q3 FY2026 · quarter ended Sep 2026
Other income / expenses turns negative
Q3 FY2026 other income / expenses was -$1.18M, compared with $1.33M a year earlier. Trailing-twelve-month other income / expenses was -$4.74M.
Context
- Other income / expenses increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near -$1.18M or moves back toward the trailing-twelve-month quarterly average of -$1.18M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 6.71M USD
- Year-over-year change
- +16.4%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.71M | +16.4% |
| FY2024 | 2024-12-31 | 5.76M | +4.6% |
| FY2023 | 2023-12-31 | 5.51M | +4271.2% |
| FY2022 | 2022-12-31 | (132K) | +93.0% |
| FY2021 | 2021-12-31 | (1.88M) | — |
Other Income / Expenses vs competitors
How SRRK compares with its peers on the latest reported figures
- SRRK's LTM Sep 2026 other income / expenses of -$4.74M is the 9th highest of the 11 companies compared; the peer median is $19.58M.
- Its year-over-year change of -154.6% is the 10th highest of 11, against a peer median of +13.5%.
- Other income / expenses amounts to 830.9% of revenue for SRRK, versus a peer median of 22.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.38B | +5729.5% | +80.5% | — | |
| LTM Jun 2026 | $292.6M | +517.4% | +79.2% | 187.5% | |
| LTM Mar 2026 | $65.43M | +239.3% | — | 3.0% | |
| LTM Sep 2026 | $35.81M | +15.2% | +93.5% | — | |
| LTM Sep 2026 | $21.61M | +11.8% | -76.4% | 2.3% | |
| LTM Jun 2026 | $17.55M | -37.4% | +97.2% | — | |
| LTM Mar 2026 | $14.2M | +6.7% | +60.9% | 44.3% | |
| LTM Mar 2026 | $11.51M | +295.2% | — | 57.5% | |
| LTM Sep 2026 | -$4.74M | -154.6% | — | 830.9% | |
| LTM Jun 2026 | -$162.69M | -29.8% | — | 22.8% | |
| LTM Jun 2026 | -$183.33M | -250.6% | — | 18.2% | |
| Peer median (excluding SRRK) | $19.58M | +13.5% | +79.8% | 22.8% | |
Competitors are the stored peer set for SRRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 18.82M | 33.19M | 0 | 0 | 0 |
| Cost of Revenue | 108.47M | 123.04M | 2.84M | 1.94M | 208.44M |
| Gross Profit | (89.65M) | (89.85M) | (2.84M) | (1.94M) | (208.44M) |
| Gross Margin | -476.5% | -270.7% | — | — | — |
| Research & Development | 108.47M | 124.44M | 119.06M | 182.61M | 208.44M |
| Selling, General & Admin | 40.27M | 42.62M | 49.4M | 67.5M | 176.21M |
| Operating Expenses | 40.27M | 44.52M | 168.45M | 250.12M | 176.21M |
| Depreciation & Amortization | 2.63M | 2.99M | 2.84M | 1.94M | 1.66M |
| EBITDA | (129.17M) | (129.48M) | (162.95M) | (237.52M) | (369.39M) |
| EBITDA Margin | -686.5% | -390.1% | — | — | — |
| Operating Income | (129.92M) | (134.37M) | (171.3M) | (252.05M) | (384.65M) |
| Operating Margin | -690.5% | -404.8% | — | — | — |
| Interest Income | 0 | 0 | 0 | 12.68M | 13.9M |
| Interest Expense | 0 | 0 | 0 | 6.84M | 6.89M |
| Other Income / Expenses | (1.88M) | (132K) | 5.51M | 5.76M | 6.71M |
| Income Before Tax | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Pre-Tax Margin | -700.5% | -405.2% | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (131.8M) | (134.5M) | (165.79M) | (246.29M) | (377.94M) |
| Net Margin | -700.5% | -405.2% | — | — | — |
| EPS (Basic) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| EPS (Diluted) | (3.59) | (2.21) | (1.99) | (2.47) | (3.29) |
| Weighted Avg Shares | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
| Weighted Avg Shares (Diluted) | 36.71M | 59.61M | 75.98M | 99.84M | 114.7M |
Scholar Rock Holding Corporation
NASDAQ:SRRK
Intrinsic Alpha fair value
Locked
Current Price
$48.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.